Live Feeds

Source map — Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
Ars Technica news 60%
The Guardian news 60%
Reuters news 60%
Scientific American news 60%
NBC News news 60%
Fierce Biotech news 60%
CNBC news 60%
Eli Lilly news 60%
USA Today news 60%
Yahoo news 60%
www.advisory.com news 50%
medicalxpress.com news 50%
www.fool.com news 50%
scitechdaily.com news 50%
peptidelibrary.io news 50%
www.matterfact.com news 50%
worldattention.com news 50%
onthepen.com news 50%
www.biospace.com news 50%
knowridge.com news 50%
www.eli.org news 50%
www.trialsitenews.com news 50%
www.mogazmasr.com news 50%
www.timothysykes.com news 50%
welltica.com news 50%
www.healthspectra.com news 50%
www.medscape.com news 50%
kures.co news 50%
www.prnewswire.com news 50%
gizmodo.com news 50%
ctv.veeva.com news 50%
biotech-insider.com news 50%
finance.yahoo.com news 50%
www.speedtest.net news 50%
intelligence.speedtest.net news 50%
ciscoconnect.speedtest.net news 50%
linksys.speedtest.net news 50%
www.cnbc.com news 50%
stockanalysis.com news 50%
rocketnews.com news 50%
www.yahoo.com news 50%
www.technologyreview.com news 50%
dispatchtimes.com news 50%
www.gotquestions.org news 50%
elireview.com news 50%
www.christianity.com news 50%
pharmaphorum.com news 50%
biblehub.com news 50%
longbridge.com news 50%
en.wikipedia.org news 50%
www.youtube.com news 50%